Selbyville, Delaware, Dec. 01, 2020 (GLOBE NEWSWIRE) -- According to credible estimations, global allergy immunotherapy market generated revenues worth USD 2.9 billion and is likely to showcase a y-o-y growth rate of 10.85% between 2020 and 2027. This rapid expansion is primarily driven by increased pervasiveness of allergic reactions and rising cognizance regarding allergy treatment.
The report also offers a detailed SWOT assessment of the various companies operating in this business sphere. Apart from this, the research report scrutinizes and provides reliable information regarding the effect of COVID-19 outbreak on the valuation as well as the growth rate of the overall market in the upcoming years, further ensuring effective decision making while making investments in new projects.
According to EAACI (European Academy of Allergy & Clinical Immunology), around 150 million people are suffering from chronic food allergies, which is approximately 20% of overall population in Europe. The agency further claimed that asthma and rhinitis are the most common type of allergies found in Europe, affecting around 70 million and 100 million people respectively. This has evidently impelled the demand for allergy immunotherapies, which in turn is facilitating the overall business scenario.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3029645/
For those unfamiliar, allergy immunotherapy is a treatment that prevents allergic reactions caused by bee venom, dust, grass pollen, and fruits among others. It helps in controlling symptoms associated with allergies such as conjunctivitis, asthma and rhinitis, which in turn is augmenting global allergy immunotherapy industry remuneration.
Apart from this, escalating clinical R&D investments by public and private organizations is also driving the growth of the market. Various companies are conducting business-centric strategies such as partnerships & agreements, acquisitions & mergers and innovative product launches in order to gain a competitive edge in this business sphere.
In October 2017 for instance, DBV Technologies teamed up with Stallergenes S.A. to boost research and development activities related to allergies, thereby favoring global allergy immunotherapy market scenario. It is worth mentioning that, however, lack of skilled professionals and high costs of procedures may act as a restraining factor to the growth of the overall market.
A synopsis of regional spectrum
On the regional basis, worldwide allergy immunotherapy market is bifurcated into Latin America, North America, Europe, Asia-Pacific and rest of the world.
As per authentic predictions, North America currently accounts for the highest market share and is set to record consistent growth during the study period, primarily driven by surging clinical R&D investments and increasing awareness pertaining to allergy care.
On the other hand, Asia-Pacific allergy immunotherapy industry is likely to display the highest CAGR through 2027, owing to high occurrence of allergic diseases.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
https://www.marketstudyreport.com/reports/global-allergy-immunotherapy-market-size-research
Global Allergy Immunotherapy Market by Treatment (Revenue, USD Billion, 2017-2027)
- Sublingual Therapy (SLIT)
- Subcutaneous Therapy (SCIT)
Global Allergy Immunotherapy Market by Allergy Type (Revenue, USD Billion, 2017-2027)
- Stinging Insect Venom
- Allergic Venom
- Allergic Conjunctivitis
- Allergic Rhinitis
Global Allergy Immunotherapy Market by Distribution Channel (Revenue, USD Billion, 2017-2027)
- Pharmacy
- E-commerce
- Hospitals
Global Allergy Immunotherapy Market Regional Scope (Revenue, USD Billion, 2017-2027)
North America
- Canada
- United States
Latin America
- Mexico
- Brazil
Europe
- Italy
- Spain
- France
- Germany
- United Kingdom
- Rest of Europe
Asia-Pacific
- South Korea
- Australia
- Japan
- China
- India
- Rest of Asia-Pacific
Global Allergy Immunotherapy Market Competitive Analysis (Revenue, USD Billion, 2017-2027)
- DBV Technologies SA
- Circassia Pharmaceuticals
- Aimmune Therapeutics
- Anergis SA
- Biomay AG
- HAL Allergy Group
- Merck Group
- Allergy Therapeutics
- ALK-Abelló A/S
- Stallergenes Greer Ltd.
Table of content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Allergy Immunotherapy Market, by Region, 2018-2027 (USD Billion)
1.2.2. Allergy Immunotherapy Market, by Treatment, 2018-2027 (USD Billion)
1.2.3. Allergy Immunotherapy Market, by Allergy, 2018-2027 (USD Billion)
1.2.4. Allergy Immunotherapy Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Allergy Immunotherapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Allergy Immunotherapy Market Dynamics
3.1. Allergy Immunotherapy Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Allergy Immunotherapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Allergy Immunotherapy Market, by Treatment
5.1. Market Snapshot
5.2. Global Allergy Immunotherapy Market by Treatment, Performance - Potential Analysis
5.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Treatment 2017-2027 (USD Billion)
5.4. Allergy Immunotherapy Market, Sub Segment Analysis
5.4.1. Subcutaneous Therapy (SCIT)
5.4.2. Sublingual Therapy (SLIT)
Chapter 6. Global Allergy Immunotherapy Market, by Allergy
6.1. Market Snapshot
6.2. Global Allergy Immunotherapy Market by Allergy, Performance - Potential Analysis
6.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Allergy 2017-2027 (USD Billion)
6.4. Allergy Immunotherapy Market, Sub Segment Analysis
6.4.1. Allergic rhinitis
6.4.2. Allergic conjunctivitis
6.4.3. Allergic asthma
6.4.4. Stinging insect venom
6.4.5. Others
Chapter 7. Global Allergy Immunotherapy Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Allergy Immunotherapy Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)
7.4. Allergy Immunotherapy Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. E-commerce
7.4.3. Pharmacy
Chapter 8. Global Allergy Immunotherapy Market, Regional Analysis
Related Report:
Global Immunotherapy Drugs Market Size study with COVID-19 Impact, Regional Forecasts 2020-2027
Global Immunotherapy Drugs Market is valued approximately USD 146.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11 % over the forecast period 2020-2027, as per new research report. Immunotherapy drugs are used to enhance the immunity of human body, the drug stimulates the immune system of the body and generate an immune response aiding the production of antibodies that are produced against antigen to kill the cancerous or tumor cells. Immunotherapy Drugs is being highly demanded for enhancing the immune system during the coronavirus pandemic across the world.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.